BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Tong Z, Sun S, Mao Z. Enhancement of tumour penetration by nanomedicines through strategies based on transport processes and barriers. J Control Release 2020;328:28-44. [PMID: 32858072 DOI: 10.1016/j.jconrel.2020.08.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Bie N, Yong T, Wei Z, Gan L, Yang X. Extracellular vesicles for improved tumor accumulation and penetration. Adv Drug Deliv Rev 2022;188:114450. [PMID: 35841955 DOI: 10.1016/j.addr.2022.114450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zeng Y, Yu T, Zhang S, Song G, Meng T, Yuan H, Hu F. Combination of tumor vessel normalization and immune checkpoint blockade for breast cancer treatment via multifunctional nanocomplexes. Biomater Sci 2022. [PMID: 35726757 DOI: 10.1039/d2bm00600f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Adv Sci (Weinh) 2022;:e2201734. [PMID: 35652198 DOI: 10.1002/advs.202201734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zhang M, Wang W, Ma H, Yu B, Cong H, Shen Y. A site-oriented nanosystem for active transcellular chemo-immunotherapy to prevent tumor growth and metastasis. Sci China Mater 2022;65:1391-402. [DOI: 10.1007/s40843-021-1846-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cheng DB, Zhang XH, Chen SY, Xu XX, Wang H, Qiao ZY. Intracellular Self-Immolative Polyprodrug with Near-Infrared Light Guided Accumulation and in Vivo Visualization of Drug Release. Adv Mater 2022;34:e2109528. [PMID: 34933400 DOI: 10.1002/adma.202109528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ding Y, Tong Z, Jin L, Ye B, Zhou J, Sun Z, Yang H, Hong L, Huang F, Wang W, Mao Z. An NIR Discrete Metallacycle Constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for Imaging-Guided Cancer Radio-Chemotherapy. Adv Mater 2022;34:e2106388. [PMID: 34821416 DOI: 10.1002/adma.202106388] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
8 Yan H, Zhang Y, Zhang Y, Li Y, Kong X, Liu D, Li J, Xi Y, Ji J, Ye L, Zhai G. A ROS-responsive biomimetic nano-platform for enhanced chemo-photodynamic-immunotherapy efficacy. Biomater Sci 2022. [DOI: 10.1039/d2bm01291j] [Reference Citation Analysis]
9 Souri M, Soltani M, Moradi Kashkooli F, Kiani Shahvandi M. Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles. J Control Release 2021;341:227-46. [PMID: 34822909 DOI: 10.1016/j.jconrel.2021.11.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
10 Li J, Wang Y, Xu C, Yu Q, Wang X, Xie H, Tian L, Qiu Y, Guo R, Lu Z, Li M, He Q. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy. Acta Biomater 2021;134:546-58. [PMID: 33882357 DOI: 10.1016/j.actbio.2021.04.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
11 Li Z, Yang Y, Wei H, Shan X, Wang X, Ou M, Liu Q, Gao N, Chen H, Mei L, Zeng X. Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy. J Control Release 2021;338:719-30. [PMID: 34509586 DOI: 10.1016/j.jconrel.2021.09.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 71] [Article Influence: 59.0] [Reference Citation Analysis]
12 Yi X, Shen M, Liu X, Gu J. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer. Nanoscale 2021;13:13943-61. [PMID: 34477676 DOI: 10.1039/d1nr03034e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Della Pelle G, Kostevšek N. Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers. Int J Mol Sci 2021;22:5264. [PMID: 34067699 DOI: 10.3390/ijms22105264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Hu J, Yuan X, Wang F, Gao H, Liu X, Zhang W. The progress and perspective of strategies to improve tumor penetration of nanomedicines. Chinese Chemical Letters 2021;32:1341-7. [DOI: 10.1016/j.cclet.2020.11.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 64] [Article Influence: 52.0] [Reference Citation Analysis]
15 Kim J, Hong J, Lee J, Fakhraei Lahiji S, Kim Y. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy. Journal of Controlled Release 2021;332:109-26. [DOI: 10.1016/j.jconrel.2021.02.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
16 Huang D, Sun L, Huang L, Chen Y. Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect. J Pers Med 2021;11:124. [PMID: 33672813 DOI: 10.3390/jpm11020124] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 28.0] [Reference Citation Analysis]
17 Phung CD, Tran TH, Choi JY, Jeong JH, Ku SK, Yong CS, Kim JO. Pre- and Post-Transcriptional Regulation of cFLIP for Effective Cancer Therapy Using pH-Ultrasensitive Nanoparticles. ACS Appl Mater Interfaces 2021;13:5999-6010. [PMID: 33506682 DOI: 10.1021/acsami.0c20624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Mochizuki C, Nakamura J, Nakamura M. Development of Non-Porous Silica Nanoparticles towards Cancer Photo-Theranostics. Biomedicines 2021;9:73. [PMID: 33451074 DOI: 10.3390/biomedicines9010073] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
19 Jangid AK, Jain P, Pooja D, Kulhari H. Introduction to Nanomedicines: Basic Concept and Applications. Emerging Trends in Nanomedicine 2021. [DOI: 10.1007/978-981-15-9920-0_1] [Reference Citation Analysis]